Masood Naseripour

2.3k total citations
81 papers, 1.6k citations indexed

About

Masood Naseripour is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Masood Naseripour has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Ophthalmology, 39 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Oncology. Recurrent topics in Masood Naseripour's work include Ocular Oncology and Treatments (41 papers), Retinal Diseases and Treatments (19 papers) and Corneal Surgery and Treatments (18 papers). Masood Naseripour is often cited by papers focused on Ocular Oncology and Treatments (41 papers), Retinal Diseases and Treatments (19 papers) and Corneal Surgery and Treatments (18 papers). Masood Naseripour collaborates with scholars based in Iran, United States and France. Masood Naseripour's co-authors include Carol L. Shields, Jerry A. Shields, Khalil Ghasemi Falavarjani, Mehdi Modarres, Habib Ghaznavi, Azam Hosseinzadeh, Saeed Mehrzadi, Jorge E. Freire, Jacqueline Cater and Ahad Sedaghat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Ophthalmology.

In The Last Decade

Masood Naseripour

75 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masood Naseripour Iran 20 1.2k 558 266 239 198 81 1.6k
Mario Damiano Toro Italy 27 1.6k 1.3× 1.1k 1.9× 115 0.4× 388 1.6× 110 0.6× 148 2.1k
Banu Bozkurt Türkiye 25 1.0k 0.9× 608 1.1× 142 0.5× 220 0.9× 35 0.2× 123 1.7k
Po‐Ting Yeh Taiwan 23 1.0k 0.9× 1.1k 2.0× 159 0.6× 198 0.8× 33 0.2× 72 1.7k
Valentín Huerva Spain 18 655 0.6× 397 0.7× 149 0.6× 128 0.5× 38 0.2× 69 955
Ramazan Yağcı Türkiye 17 632 0.5× 437 0.8× 160 0.6× 270 1.1× 25 0.1× 68 1.2k
Gian Maria Cavallini Italy 20 615 0.5× 461 0.8× 149 0.6× 216 0.9× 18 0.1× 85 1.3k
Robert Haimovici United States 22 1.3k 1.1× 651 1.2× 123 0.5× 458 1.9× 28 0.1× 28 1.7k
Yedi Zhou China 22 627 0.5× 372 0.7× 96 0.4× 687 2.9× 53 0.3× 70 1.5k
Andreas Katsanos Greece 26 1.6k 1.3× 876 1.6× 223 0.8× 201 0.8× 28 0.1× 105 1.9k
Katherine E. Talcott United States 19 992 0.8× 678 1.2× 172 0.6× 381 1.6× 57 0.3× 114 1.6k

Countries citing papers authored by Masood Naseripour

Since Specialization
Citations

This map shows the geographic impact of Masood Naseripour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masood Naseripour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masood Naseripour more than expected).

Fields of papers citing papers by Masood Naseripour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masood Naseripour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masood Naseripour. The network helps show where Masood Naseripour may publish in the future.

Co-authorship network of co-authors of Masood Naseripour

This figure shows the co-authorship network connecting the top 25 collaborators of Masood Naseripour. A scholar is included among the top collaborators of Masood Naseripour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masood Naseripour. Masood Naseripour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naseripour, Masood, et al.. (2023). Semi-supervised segmentation of retinoblastoma tumors in fundus images. Scientific Reports. 13(1). 13010–13010. 11 indexed citations
2.
Naseripour, Masood, et al.. (2023). Congenital simple hamartoma of the retinal pigment epithelium: 4 cases with multimodal imaging. Ophthalmic Genetics. 45(1). 78–83. 1 indexed citations
3.
Fard, Atousa Moghadam, Reza Mirshahi, Masood Naseripour, & Khalil Ghasemi Falavarjani. (2023). Stem Cell Therapy in Stargardt Disease: A Systematic Review. Journal of Ophthalmic and Vision Research. 18(3). 318–327. 4 indexed citations
4.
Chegini, Zahra, Masood Naseripour, Hossein Aghaei, et al.. (2023). Molecular Analysis of the Ocular Microbiome Dominant Bacteria in Conjunctival Squamous Cell Carcinoma Patients. Iranian Journal of Medical Microbiology. 17(6). 654–662. 1 indexed citations
5.
Naseripour, Masood, et al.. (2023). Double Retina Sign: A New Optical Coherence Tomography Finding in Combined Hamartoma of the Retina and Retinal Pigment Epithelium. Journal of Current Ophthalmology. 35(1). 90–92. 1 indexed citations
6.
Mohseni, Mojdeh, et al.. (2022). Lauric acid-grafted biopolymeric nanoparticles for efficient Melphalan delivery across the corneal layers for retinoblastoma: ex vivo and in vivo permeation study. Advances in Natural Sciences Nanoscience and Nanotechnology. 13(3). 35005–35005. 6 indexed citations
7.
Naseripour, Masood, Ahad Sedaghat, Reza Mirshahi, et al.. (2022). Targeted chemotherapy in retinoblastoma: A step forward from patient survival to globe survival. European Journal of Ophthalmology. 33(1). 574–586. 5 indexed citations
8.
Mirshahi, Reza, et al.. (2022). Ruthenium-106 plaque radiotherapy for uveal melanoma: analysis of tumor dimension and location on anatomical and functional results. BMC Ophthalmology. 22(1). 309–309. 10 indexed citations
9.
Naseripour, Masood, et al.. (2022). Cystoid macular oedema without leakage in fluorescein angiography: a literature review. Eye. 37(8). 1519–1526. 4 indexed citations
10.
Naseripour, Masood, et al.. (2022). Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes. OncoTargets and Therapy. Volume 15. 1545–1561. 4 indexed citations
11.
Aghdam, Kaveh Abri, et al.. (2021). The Impacts of Episcleral Plaque Brachytherapy on Ocular Motility. PubMed. 71(2). 55–61. 2 indexed citations
12.
Naseripour, Masood, Khalil Ghasemi Falavarjani, Reza Mirshahi, & Ahad Sedaghat. (2020). Optical coherence tomography angiography (OCTA) applications in ocular oncology. Eye. 34(9). 1535–1545. 26 indexed citations
13.
Naseripour, Masood, et al.. (2016). Corneal Patch Graft. Cornea. 35(4). 565–568. 8 indexed citations
14.
Falavarjani, Khalil Ghasemi, Mohamadreza Aghamirsalim, Mehdi Modarres, et al.. (2015). Endophthalmitis after resident-performed intravitreal bevacizumab injection. Canadian Journal of Ophthalmology. 50(1). 33–36. 16 indexed citations
15.
Kashkouli, Mohsen Bahmani, et al.. (2012). Long-term follow-up of invasive ocular surface squamous cell carcinoma treated with excision, cryotherapy, and topical mitomycin C. Graefe s Archive for Clinical and Experimental Ophthalmology. 250(10). 1527–1532. 11 indexed citations
16.
Naseripour, Masood, et al.. (2009). Ruthenium-106 Plaque Radiotherapy for Retinal Vasoproliferative Tumors. 21(2). 31–35. 1 indexed citations
17.
Naseripour, Masood, et al.. (2009). Retinoblastoma Survival in Iran: 10 Years Experience of a Referral Center. 21(4). 17–24. 4 indexed citations
18.
Kashkouli, Mohsen Bahmani, Shabnam Salimi, Pejman Bakhtiari, et al.. (2008). EMLA Cream Application Without Occlusive Dressing Before Upper Facial Botulinum Toxin Injection. Annals of Plastic Surgery. 60(4). 353–356. 9 indexed citations
19.
Kashkouli, Mohsen Bahmani, et al.. (2007). Bilateral Pseudomonas aeruginosa endophthalmitis following bilateral simultaneous cataract surgery. Indian Journal of Ophthalmology. 55(5). 374–374. 43 indexed citations
20.
Sanjari, Mostafa Soltan, et al.. (2006). VITREOPAPILLARY TRACTION IN NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY. SHILAP Revista de lepidopterología. 1(2). 110–112. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026